Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11209057.
- Also identified by PMC identifier 14634.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Induction of resting B cell growth and differentiation requires a complex series of temporally coordinated signals that are initiated on contact with activated helper T cells. These signals complement one another, each rendering the B cell susceptible to factors supporting progressive activation. Here, we demonstrate that soluble CD14 (sCD14) bypasses the physiological sequelae of events that limit B cell activation. B cell growth and differentiation in vitro is induced by both native and recombinant forms of sCD14 at nanomolar concentrations. sCD14-mediated cellular activation does not require membrane CD14 expression, depends on a region of CD14 that is not involved in lipopolysaccharide binding, and requires functional Toll-like receptor 4. Consistent with biological activity of sCD14 in vitro, its administration to neonatal mice enhances Ig secretion. The results presented establish sCD14 as a naturally occurring soluble B cell mitogen of mammalian origin.
Medical subject headings
- Antibody Formation
- B-Lymphocytes
- Colostrum
- Drosophila Proteins
- Lipopolysaccharide Receptors
- Lymphocyte Activation
- Milk, Human